---
document_datetime: 2025-09-17 10:05:05
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/daptomycin-hospira-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: daptomycin-hospira-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.3789919
conversion_datetime: 2025-12-30 21:22:13.248859
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Daptomycin Hospira

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific information after authorisation (archive).

| Applicationnumber    | Scope                               | Opinion/ Notification 1 issued on   | Commission Decision Issued²/ amendedon   | Product Information affected3   | Summary   |
|----------------------|-------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation typeIA_IN/ | B.II.b.2.cReplacementor additionofa | 11/09/2025                          |                                          | Annex II and                    |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000278463   | manufacturerresponsibleforimportation and/or batch release - B.11.b.2.c.1 Not includingbatch control/testing-Accepted   |            | PL   |                                  |
|---------------------|-------------------------------------------------------------------------------------------------------------------------|------------|------|----------------------------------|
|                     | ：-Accepted                                                                                                              | 12/02/2025 | PL   | Article 61(3) / EMA/N/0000245626 |